/
/
/

Caplin Point Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹610 Cr₹600 Cr₹543 Cr₹534 Cr₹510 Cr₹502 Cr₹493 Cr₹483 Cr₹459 Cr₹453 Cr₹436 Cr₹410 Cr₹395 Cr₹389 Cr₹372 Cr₹359 Cr₹346 Cr₹339 Cr₹326 Cr₹304 Cr₹300 Cr₹279 Cr₹274 Cr₹268 Cr₹240 Cr₹215 Cr₹228 Cr₹227 Cr₹193 Cr₹187 Cr₹159 Cr₹156 Cr₹146 Cr₹143 Cr₹142 Cr₹131 Cr₹124 Cr₹118 Cr₹103 Cr₹96 Cr₹85 Cr₹82 Cr₹79 Cr₹78 Cr₹70 Cr₹64 Cr₹61 Cr₹57 Cr₹48 Cr₹43 Cr₹43 Cr₹41 Cr₹39 Cr₹29 Cr₹32 Cr₹27 Cr
₹34 Cr₹28 Cr₹34 Cr₹30 Cr₹23 Cr₹26 Cr₹31 Cr₹21 Cr₹19 Cr₹17 Cr₹17 Cr₹20 Cr₹12 Cr₹11 Cr₹14 Cr₹16 Cr₹14 Cr₹12 Cr₹10 Cr₹8 Cr₹9 Cr₹9 Cr₹6 Cr₹2 Cr₹6 Cr₹20 Cr₹10 Cr₹7 Cr₹4 Cr₹3 Cr₹8 Cr₹7 Cr₹2 Cr₹3 Cr₹2 Cr₹4 Cr₹4 Cr₹4 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹1 Cr₹90 L₹91 L₹70 L₹81 L₹71 L₹91 L₹1 Cr₹95 L₹55 L₹39 L₹41 L₹56 L₹4 Cr
₹644 Cr₹629 Cr₹576 Cr₹564 Cr₹533 Cr₹528 Cr₹524 Cr₹504 Cr₹478 Cr₹471 Cr₹453 Cr₹430 Cr₹407 Cr₹401 Cr₹386 Cr₹376 Cr₹360 Cr₹351 Cr₹336 Cr₹312 Cr₹310 Cr₹288 Cr₹280 Cr₹270 Cr₹247 Cr₹235 Cr₹239 Cr₹234 Cr₹197 Cr₹190 Cr₹167 Cr₹163 Cr₹148 Cr₹146 Cr₹144 Cr₹135 Cr₹127 Cr₹122 Cr₹105 Cr₹98 Cr₹86 Cr₹83 Cr₹80 Cr₹78 Cr₹71 Cr₹64 Cr₹62 Cr₹58 Cr₹49 Cr₹44 Cr₹44 Cr₹41 Cr₹40 Cr₹29 Cr₹32 Cr₹31 Cr
₹419 Cr₹415 Cr₹372 Cr₹363 Cr₹349 Cr₹351 Cr₹347 Cr₹335 Cr₹323 Cr₹324 Cr₹307 Cr₹284 Cr₹280 Cr₹276 Cr₹274 Cr₹265 Cr₹255 Cr₹251 Cr₹237 Cr₹214 Cr₹220 Cr₹203 Cr₹200 Cr₹190 Cr₹177 Cr₹170 Cr₹169 Cr₹163 Cr₹133 Cr₹129 Cr₹107 Cr₹106 Cr₹99 Cr₹101 Cr₹95 Cr₹86 Cr₹81 Cr₹80 Cr₹74 Cr₹71 Cr₹66 Cr₹64 Cr₹59 Cr₹59 Cr₹55 Cr₹50 Cr₹50 Cr₹47 Cr₹40 Cr₹33 Cr₹34 Cr₹36 Cr₹36 Cr₹24 Cr₹27 Cr₹23 Cr
₹247 Cr₹233 Cr₹223 Cr₹220 Cr₹201 Cr₹194 Cr₹194 Cr₹186 Cr₹170 Cr₹163 Cr₹159 Cr₹158 Cr₹139 Cr₹135 Cr₹124 Cr₹122 Cr₹116 Cr₹111 Cr₹111 Cr₹110 Cr₹102 Cr₹95 Cr₹90 Cr₹89 Cr₹78 Cr₹73 Cr₹78 Cr₹78 Cr₹72 Cr₹67 Cr₹65 Cr₹63 Cr₹55 Cr₹52 Cr₹53 Cr₹53 Cr₹50 Cr₹48 Cr₹34 Cr₹30 Cr₹24 Cr₹22 Cr₹24 Cr₹22 Cr₹20 Cr₹16 Cr₹14 Cr₹13 Cr₹10 Cr₹12 Cr₹10 Cr₹6 Cr₹4 Cr₹6 Cr₹6 Cr₹8 Cr
₹18 L₹36 L₹18 L₹16 L₹18 L₹17 L₹18 L₹21 L₹5 L₹15 L₹17 L₹18 L₹28 L₹23 L₹36 L₹14 L₹6 L₹8 L₹14 L₹21 L₹27 L₹32 L₹28 L₹48 L₹51 L₹17 L₹6 L₹8 L₹1 L₹1 L₹2 L₹2 L₹1 L₹1 L₹2 L₹2 L₹2 L₹2 L₹2 L₹5 L₹3 L₹3 L₹5 L₹3 L₹10 L₹4 L₹5 L₹5 L₹5 L₹2 L₹2 L₹4 L₹15 L₹3 L₹2 L₹11 L
₹225 Cr₹213 Cr₹204 Cr₹201 Cr₹184 Cr₹177 Cr₹177 Cr₹169 Cr₹154 Cr₹146 Cr₹145 Cr₹146 Cr₹127 Cr₹124 Cr₹112 Cr₹110 Cr₹105 Cr₹100 Cr₹99 Cr₹98 Cr₹90 Cr₹85 Cr₹80 Cr₹80 Cr₹69 Cr₹65 Cr₹70 Cr₹71 Cr₹64 Cr₹61 Cr₹60 Cr₹57 Cr₹49 Cr₹45 Cr₹49 Cr₹48 Cr₹46 Cr₹43 Cr₹31 Cr₹27 Cr₹21 Cr₹19 Cr₹21 Cr₹19 Cr₹16 Cr₹15 Cr₹12 Cr₹11 Cr₹9 Cr₹11 Cr₹10 Cr₹6 Cr₹4 Cr₹5 Cr₹6 Cr₹7 Cr
₹179 Cr₹173 Cr₹166 Cr₹160 Cr₹151 Cr₹145 Cr₹140 Cr₹131 Cr₹125 Cr₹121 Cr₹120 Cr₹116 Cr₹104 Cr₹101 Cr₹97 Cr₹92 Cr₹86 Cr₹81 Cr₹79 Cr₹77 Cr₹72 Cr₹68 Cr₹66 Cr₹63 Cr₹55 Cr₹49 Cr₹59 Cr₹57 Cr₹50 Cr₹50 Cr₹46 Cr₹43 Cr₹37 Cr₹35 Cr₹37 Cr₹36 Cr₹36 Cr₹33 Cr₹24 Cr₹22 Cr₹16 Cr₹16 Cr₹16 Cr₹14 Cr₹13 Cr₹11 Cr₹9 Cr₹9 Cr₹7 Cr₹7 Cr₹8 Cr₹4 Cr₹2 Cr₹3 Cr₹4 Cr₹5 Cr

Share Price Live Stats

Open (₹)2,845.00
Volume (₹)2.09 L
High (₹)2,845.00
Upper Circuit3,414.00
Low (₹)2,759.60
Lower Circuit2,276.00
Prev Close2,845.00
52W High (₹)2,877.30
Price2,810.80
52W Low (₹)1,500.30

Share Market Cap & Key Ratios Overview

M.Cap (₹)21608.60 Cr
Div. Yield (%)0.28
PE Ratio51.48
Debt to Equity0.00
Price to Book5.63
Book Value267.39
EPS (TTM)55.22
Face Value2.00
ROE (%)21.36

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
CAPLIPOINTNSE
LTP
1W Low
1W High
Market cap (₹)
1899-21 (-1.09%)
1895
1984.80
4,56,833Cr
9100-139 (-1.50%)
9087
9467
2,45,426Cr
4857-193 (-3.82%)
4823
5066
1,87,320Cr
1120-71 (-5.96%)
1120
1187
1,13,217Cr
1385-38.5 (-2.70%)
1375.50
1426.10
1,12,212Cr
1840-98.5 (-5.08%)
1811.70
1949
1,01,155Cr
2110-61.5 (-2.83%)
2100.60
2192
97,626Cr
2327.9-55 (-2.31%)
2317
2419.20
96,859Cr
1151-27 (-2.29%)
1151
1179.90
96,406Cr
1653.1+7.8 (0.47%)
1622.60
1717
93,614Cr
2810.8+293.6 (11.66%)
2492.20
2877.30
21,609Cr

Key Highlights of Caplin Point Laboratories Ltd’s P&L

In 2025-03-31, Caplin Point Laboratories Ltd reported total revenue of ₹2033.9Cr, compared with ₹1761.04Cr in 2024-03-31, reflecting Caplin Point Laboratories Ltd turnover.

Depreciation was ₹65.96Cr and finance costs were ₹61Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹676.78Cr in 2025-03-31 as compared to ₹564.43Cr in 2024-03-31.

Net Profit (PAT) was ₹536.31Cr in 2025-03-31 compared with ₹457.09Cr in 2024-03-31.

Earnings per share (EPS) were ₹70.57 in 2025-03-31, compared with ₹60.18 in 2024-03-31.